Richard Nkulikiyinka

Vericiguat and Health-Related Quality of Life in Patients With Heart Failure With Reduced Ejection Fraction: Insights From the VICTORIA Trial

Javed Butler, Amanda Stebbins, Vojtěch Melenovský et al. · Circulation Heart Failure · 2022 · 41 citations · Full text

Pharmacy, Cardiology, Pharmacotherapy +14

Development and Validation of a New Hierarchical Composite End Point for Clinical Trials of Kidney Disease Progression

Hiddo J.L. Heerspink, Niels Jongs, Patrick Schloemer et al. · Journal of the American Society of Nephrology · 2023 · 37 citations · Full text

Medicine, Biostatistics, Nephrology +11

Vericiguat for patients with heart failure and reduced ejection fraction across the risk spectrum: an individual participant data analysis of the VICTORIA and VICTOR trials

Faı̈ez Zannad, Christopher M. O’Connor, Javed Butler et al. · The Lancet · 2025 · 32 citations · Full text

Pharmacy, Cardiology, Pharmacotherapy +17

A phase 3 randomized, double-blind, vehicle-controlled trial of azelaic acid foam 15% in the treatment of papulopustular rosacea.

Zoe Diana Draelos, Boni E. Elewski, Julie Harper et al. · PubMed · 2015 · 28 citations

Medicine, Dermatology, Pharmacology +17

Age, Sex, and Outcomes in Heart Failure With Reduced EF

Carolyn S.P. Lam, Ileana L. Piña, Yinggan Zheng et al. · JACC Heart Failure · 2023 · 27 citations · Full text

Medicine, Cardiology, Internal Medicine +13